The Ames assay employing Salmonella typhimurium TA100 and TA98 was used to investigate potential interactions between aflatoxin B1 (AFB1) and the phenolic antioxidants butylated hydroxytoluene, butylated hydroxyanisole, and propyl gallate. AFB1 doses were within the linear response range, and the antioxidants were used at levels of 0 to 50 jig per plate. All three antioxidants were nonmutagenic in either bacterial tester strain, with or without the hepatic S-9 enzyme preparation; toxic effects were observed at doses higher than 20 ,ug per plate. Butylated hydroxytoluene and butylated hydroxyanisole substantially increased AFB1-induced mutagenesis in the two tester strains with microsomal activation. The addition of 5 to 20 ,ug of butylated hydroxytoluene or hydroxyanisole to 5 to 20 ng of AFB1 per plate caused more than a twofold increase in the number of His' revertants. Addition of propyl gallate resulted in only a moderate increase in the number of revertants. Whereas several anticarcinogenic and antimutagenic effects by phenolic antioxidants have been reported, particularly in studies with polycycic aromatic hydrocarbons, the enhancement of mutagenic potency of AFBI by these compounds suggests a specificity with respect to the chemical nature of AFB1.
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The phenolic antioxidants 3,5-di-tert-butyl-4-hydroxytoluene (BHT), 2(3)-tert-butyl-4-hydroxyanisole (BHA), and 3,4,5-trihydroxybenzoic acid propyl ester (propyl gallate; PG) are used extensively as food additives to increase the shelf life of food products by protecting against lipid oxidation. Foods covered by the U.S. Food and Drug Administration may contain a total of 0.02% of these antioxidants based on the fat content of the food (20) . It is estimated that a U.S. resident consumes approximately 2 mg of phenolic antioxidants daily (9) .
Because of their widespread use, several studies on the safety of antioxidants have been conducted. Most toxicological experiments were done with rodents, and some were done with monkeys. A variety of effects were produced by feeding experimental animals higher doses than those used for food preservation. These included reduced growth rate, reduced body weight, and elevated serum cholesterol in rats (11), hyperplasia in mice (6), tumor promotion (25) , and changes in the activity of liver enzymes (4) . Changes in enzymatic activities by phenolic antioxidants reflect differences in the responses of monkeys and rodents.
Although the information on carcinogenicity of phenolic antioxidants is limited, anticarcinogenic and antimutagenic properties have been ascribed to these compounds, particularly with respect to aromatic polycyclic hydrocarbons (2, 7, 10, 12, 15, 16, 18, 19, 23, 24) . The anticarcinogenic activity was generally studied by induction of tumors in experimental animals after or during administration of antioxidants. Antimutagenic activities were assessed by the Ames assay, which has been used as a rapid test for screening mutagens and to provide predictive values for animal carcinogenicity (1) . Aflatoxin B, (AFB1) is the most potent known liver carcinogen for experimental animals and a suspected cause of human cancer. The incidence of primary liver cancer in humans has been associated with high levels of aflatoxin intake (17, 26) . The compound is also a potent mutagen (14) . Accidentally ingested aflatoxins may be transported to and metabolized in the human liver in the presence of phenolic antioxidants, which are only slowly released from the body (8 Bacterial strains. Histidine auxotrophs of Sal-monella typhimurium strains TA100 (base pair mutation, hisG-46) and TA98 (frameshift mutation, hisD3052), bearing the plasmid pKM101, were generously provided by B. N. Ames. The strains were checked routinely for ampicillin resistance, crystal violet sensitivity, and ultraviolet light sensitivity. Liver homogenates (S-9) were prepared from Aroclor 1254-induced rats (Sprague-Dawley males) as described by Ames et al. (1) . Tubes containing 5 ml of sterile nutrient broth (Difco Laboratories, Detroit, Mich.) were inoculated with the tester strains from refrigerated master plates. The cells were grown on a shaker for 20 h at 37°C. A 0.1-ml portion of bacterial tester strain culture was added to top agar at 45°C, followed by AFB, and the antioxidant, in no more than 0.1 ml of dimethyl sulfoxide and 0.5 ml of the S-9 mix. The contents were mixed and poured on minimal glucose agar plates. Triplicate plates were poured for each combination of aflatoxin and antioxidant, and the experiments were repeated at least three times. Revertants were scored after 2 days at 37°C, using a digimatic colony counter (Lab Line Instruments, Melrose Park, Ill.) or an automatic colony counter (Fisher Scientific Co., Pittsburgh, Pa.) which was calibrated against the former. The dose-response curves for AFB, and the optimal amounts of S-9 were experimentally predetermined, and AFBJ levels within the linear region of the dose-response curves were used in studies with antioxidants. The effects of each of the phenolic antioxidants on growth were examined in nutrient agar plates, and doses which produced toxic effects were determined. RESULTS Toxicity of antioxidants. Increasing concentrations of the three phenolic antioxidants had toxic effects on the bacterial strains. At a concentration of 50 ,ug per plate, the percent survival in nutrient agar for strain TA100 were 83, 58, and 32 for BHT, BHA, and PG, respectively; at 100 ,ug per plate, the values were 63, 36, and 19% ( Fig. 1, 2, and 3) . Similar values were observed for strain TA98. Consequently, maximum doses of 50 ,ug of the antioxidants were used in the experiments.
Influence of antioxidants on AFB1 mutagenesis. None of the antioxidants was mutagenic in either bacterial tester strain with or without the hepatic S-9 enzyme preparation. Activated AFB, displayed a dose-response curve in agreement with published data (14, 27, 28) . The addition of BHT or BHA enhanced the mutagenic activity of AFBI. These measurements were performed with low concentrations of AFB, to provide accurate scoring of revertant colonies. The addition of 5 to 20 ,ug of BHT or BHA to 10 ng of AFBI produced the highest increase in the number of TA100 revertants ( Fig.  1 and 2) . Despite some toxicity, increasing the concentration of BHT and BHA to 50 jig also stimulated AFB1 mutagenesis, particularly with BHA. While BHT was less toxic than BHA, a higher number of revertants was scored in the presence of BHA than in that of BHT. PG produced only a moderate increase in revertant numbers (Fig. 3) . Figure 4 illustrates results with the three antioxidants. The highest number of revertants occurred in the presence of 5 Table 1 . However, His' revertants scored in the presence of the antioxidants were consistently higher than in their absence, even at antioxidant levels which showed some toxicity to the tester organisms.
All published reports heretofore have ascribed antimutagenic effects to antioxidants, mostly in demonstrations with benzo(a)pyrene and its derivatives (Table 2 ). To our knowledge, such effects have not been studied with any of the aflatoxins. We confirmed partial inhibition of mutagenicity by the addition of BHT in a system requiring microsomal activation, benzo(a)-pyrene, and in two systems not requiring acti- BHT and BHA are hindered phenolic compounds with higher antioxidative activity than PG. Their reaction products will differ from those of PG in their potential for subsequent oxidation, and this may account for the difference observed in the effect of these antioxidants on the mutagenicity of AFBI. Enhanced mutagenic activity in the Ames assay has also been reported by Sugimura et al. (22) when azo dyes were tested in the presence of riboflavin. Recently, Sugimura and Nagao (21) reported enhanced mutagenic activities of many mutacarcinogens by norharman and harman, which are found in the charred surface of fish and meat and in the pyrolysate of albumin.
Since exposure to small doses of aflatoxins over long periods of time is a potential cause of human cancer, coincidental interaction with low doses of residual antioxidants may enhance their carcinogenic properties. In vivo, the enzyme-inducing effects of the antioxidants may also be a factor in enhancing the mutagenic activity of AFB,. The concern that phenolic antioxidants may convert ingested materials to toxic carcinogenic substances by the increase of microsomal enzymes has led some countries to restrict their use as food additives. Further investigation with other mycotoxins and antioxidants, as well as other assay systems, is warranted. The ability of the Ames assay to detect in vitro alterations of responses to mutacarcinogens brought on by the presence of compounds such as food additives makes this detection system a valuable tool in predicting similar interactions in vivo.
